{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:36:40Z","timestamp":1793522200316,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple myeloma (MM) is a major health concern. Understanding the different burden and tendency of MM in different regions is crucial for formulating specific local strategies. Therefore, we evaluated the epidemiologic patterns and explored the risk factors for MM death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data on MM were collected from the 2019 Global Burden of Disease study. We used incidence, mortality, and disability adjusted life-years to estimate the global, regional, and national burden of MM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2019, there were 155,688 (95% UI, 136,585 \u2013 172,577) MM cases worldwide, of which 84,516 (54.3%, 70,924 \u2013 94,910) were of men. The age-standardized incidence rate (ASIR) was 1.72\/100,000 persons (95% UI, 1.59\u20131.93) in 1990 and 1.92\/100,000 persons (95% UI, 1.68\u20132.12) in 2019. The number of MM deaths increased 1.19-fold from 51,862 (95% UI, 47,710\u201358,979) in 1990 to 113,474 (95% UI, 99,527 \u2013 121,735) in 2019; the age-standardized death rate (ASDR) was 1.42\/100,000 persons (95% UI, 1.24\u20131.52) in 2019. In recent 15\u2009years, ASDR showed a steady tendency for men, and a downward tendency for women. Countries with high social-demographic indexes exhibited a higher ASIR and ASDR. Australasia, North America, and Western Europe had the highest ASIR and ASDR, with 46.3% incident cases and 41.8% death cases. Monaco had the highest ASIR and ASDR, which was almost half as high as the second highest country Barbados. In addition, United Arab Emirates and Qatar had the largest growth multiple in ASIR and ASDR, which was twice the third country Djibouti.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Globally, incident and death MM cases have more than doubled over the past 30\u2009years. The increasing global burden may continue with population aging, whereas mortality may continue to decrease with the progression of medical technology. The global burden pattern of MM was diverse, therefore specific local strategies based on different burden patterns for MM are necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-08280-y","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T13:02:51Z","timestamp":1621947771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019"],"prefix":"10.1186","volume":"21","author":[{"given":"Linghui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"8280_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"8280_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int J Cancer"},{"issue":"11","key":"8280_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046\u201360. https:\/\/doi.org\/10.1056\/NEJMra1011442.","journal-title":"N Engl J Med"},{"issue":"6","key":"8280_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","volume":"43","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin Oncol. 2016;43(6):676\u201381. https:\/\/doi.org\/10.1053\/j.seminoncol.2016.11.004.","journal-title":"Semin Oncol"},{"issue":"15","key":"8280_CR5","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","volume":"25","author":"SY Kristinsson","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bj\u00f6rkholm M. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(15):1993\u20139. https:\/\/doi.org\/10.1200\/JCO.2006.09.0100.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology."},{"issue":"5","key":"8280_CR6","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1182\/blood-2007-08-104984","volume":"111","author":"H Brenner","year":"2008","unstructured":"Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood. 2008;111(5):2521\u20136. https:\/\/doi.org\/10.1182\/blood-2007-08-104984.","journal-title":"Blood."},{"issue":"5","key":"8280_CR7","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","volume":"111","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111(5):2516\u201320. https:\/\/doi.org\/10.1182\/blood-2007-10-116129.","journal-title":"Blood."},{"key":"8280_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66:443\u201359.","journal-title":"CA Cancer J Clin"},{"key":"8280_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;385:117\u201371.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"8280_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/JU.0000000000000025","volume":"201","author":"H Ebrahimi","year":"2019","unstructured":"Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, et al. Global, regional and National Burden of bladder Cancer, 1990 to 2016: results from the GBD study 2016. J Urol. 2019;201(5):893\u2013901. https:\/\/doi.org\/10.1097\/JU.0000000000000025.","journal-title":"J Urol"},{"key":"8280_CR11","volume-title":"R Foundation for statistical computing","author":"R Core Team","year":"2018","unstructured":"R Core Team. R: a language and environment for statistical computing. In: R Foundation for statistical computing. Vienna: URL; 2018. https:\/\/www.R-project.org\/."},{"issue":"4","key":"8280_CR12","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.7314\/APJCP.2013.14.4.2333","volume":"14","author":"N Rajabli","year":"2013","unstructured":"Rajabli N, Naeimi-Tabeie M, Jahangirrad A, Sedaghat SM, Semnani S, Roshandel G. Epidemiology of leukemia and multiple myeloma in Golestan, Iran. APJCP. 2013;14(4):2333\u20136. https:\/\/doi.org\/10.7314\/APJCP.2013.14.4.2333.","journal-title":"APJCP"},{"key":"8280_CR13","doi-asserted-by":"publisher","first-page":"A449","DOI":"10.1016\/j.jval.2015.09.1129","volume":"18","author":"I Yamabe","year":"2015","unstructured":"Yamabe I. Hiroshima. Epidemiology and Burden of Multiple Myeloma in Japan: a Systematic Review. Value Health. 2015;18:A449.","journal-title":"Value Health"},{"issue":"14","key":"8280_CR14","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1002\/cncr.32128","volume":"125","author":"M Tsang","year":"2019","unstructured":"Tsang M, Le M, Ghazawi FM, Cyr J, Alakel A, Rahme E, et al. Multiple myeloma epidemiology and patient geographic distribution in Canada: a population study. Cancer. 2019;125(14):2435\u201344. https:\/\/doi.org\/10.1002\/cncr.32128.","journal-title":"Cancer."},{"issue":"9","key":"8280_CR15","doi-asserted-by":"publisher","first-page":"A872","DOI":"10.1016\/j.jval.2017.08.2558","volume":"20","author":"M Pineli","year":"2017","unstructured":"Pineli M, Pinho W, Amigo C, Alvarado C, Figueroa R, Bucheli E. Multiple myeloma: epidemiology and burden of disease analysis in Latin America. Value Health. 2017;20(9):A872. https:\/\/doi.org\/10.1016\/j.jval.2017.08.2558.","journal-title":"Value Health"},{"issue":"5","key":"8280_CR16","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/cam4.1347","volume":"7","author":"MP Curado","year":"2018","unstructured":"Curado MP, Oliveira MM, Silva DRM, Souza DLB. Epidemiology of multiple myeloma in 17 Latin American countries: an update. Cancer Med. 2018;7(5):2101\u20138. https:\/\/doi.org\/10.1002\/cam4.1347.","journal-title":"Cancer Med"},{"issue":"9","key":"8280_CR17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","volume":"4","author":"AJ Cowan","year":"2018","unstructured":"Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, et al. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol. 2018;4(9):1221\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2128.","journal-title":"JAMA Oncol"},{"key":"8280_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2468-1253(19)30328-0","volume":"5","author":"GBD 2017 Stomach Cancer Collaborators","year":"2020","unstructured":"GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: a systematic analysis for the Global Burden of Disease study 2017. The Lancet Gastroenterol Hepatol. 2020;5:42\u201354.","journal-title":"The Lancet Gastroenterol Hepatol"},{"key":"8280_CR19","volume-title":"SEER Cancer Statistics Review, 1975-2006, National Cancer Institute","author":"L Ries","year":"2006","unstructured":"Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M, et al. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda: My Publications; 2006."},{"issue":"11","key":"8280_CR20","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1002\/cncr.20652","volume":"101","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ 3rd. Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades. Cancer. 2004;101(11):2667\u201374. https:\/\/doi.org\/10.1002\/cncr.20652.","journal-title":"Cancer."},{"issue":"3","key":"8280_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1365-2141.2004.05207.x","volume":"127","author":"KJ Phekoo","year":"2004","unstructured":"Phekoo KJ, Schey SA, Richards MA, Bevan DH, Bell S, Gillett D, et al. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol. 2004;127(3):299\u2013304. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05207.x.","journal-title":"Br J Haematol"},{"issue":"12","key":"8280_CR22","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1200\/JCO.1987.5.12.1977","volume":"5","author":"B Weston","year":"1987","unstructured":"Weston B, Grufferman S, MacMillan JP, Cohen HJ. Effects of socioeconomic and clinical factors on survival in multiple myeloma. J Clin Oncol. 1987;5(12):1977\u201384. https:\/\/doi.org\/10.1200\/JCO.1987.5.12.1977.","journal-title":"J Clin Oncol"},{"key":"8280_CR23","first-page":"1410","volume":"91","author":"RM Abou-Jawde","year":"2006","unstructured":"Abou-Jawde RM, Baz R, Walker E, Choueiri TK, Karam MA, Reed J, et al. The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma. Haematologica. 2006;91:1410\u20133.","journal-title":"Haematologica."},{"issue":"12","key":"8280_CR24","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1002\/1097-0142(19841215)54:12<3085::AID-CNCR2820541246>3.0.CO;2-Z","volume":"54","author":"D Savage","year":"1984","unstructured":"Savage D, Lindenbaum J, Van Ryzin J, Struening E, Garrett TJ. Race, poverty, and survival in multiple myeloma. Cancer. 1984;54(12):3085\u201394. https:\/\/doi.org\/10.1002\/1097-0142(19841215)54:12<3085::AID-CNCR2820541246>3.0.CO;2-Z.","journal-title":"Cancer."},{"issue":"9","key":"8280_CR25","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3109\/10428194.2015.1011156","volume":"56","author":"MA Fiala","year":"2015","unstructured":"Fiala MA, Finney JD, Liu J, Stockerl-Goldstein KE, Tomasson MH, Vij R, et al. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma. Leukemia Lymphoma. 2015;56(9):2643\u20139. https:\/\/doi.org\/10.3109\/10428194.2015.1011156.","journal-title":"Leukemia Lymphoma"},{"key":"8280_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (London, England). 2008;371:569\u201378.","journal-title":"Lancet (London, England)"},{"issue":"11","key":"8280_CR27","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/ijc.22968","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Wolk A. Body mass index and risk of multiple myeloma: a meta-analysis. Int J Cancer. 2007;121(11):2512\u20136. https:\/\/doi.org\/10.1002\/ijc.22968.","journal-title":"Int J Cancer"},{"key":"8280_CR28","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","volume":"47","author":"A Wallin","year":"2011","unstructured":"Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer (Oxford, England : 1990). 2011;47:1606\u201315.","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"issue":"1","key":"8280_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12307-009-0034-7","volume":"3","author":"D Zipori","year":"2010","unstructured":"Zipori D. The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell. Cancer Microenviron. 2010;3(1):15\u201328. https:\/\/doi.org\/10.1007\/s12307-009-0034-7.","journal-title":"Cancer Microenviron"},{"issue":"7","key":"8280_CR30","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.leu.2404658","volume":"21","author":"J Caers","year":"2007","unstructured":"Caers J, Deleu S, Belaid Z, De Raeve H, Van Valckenborgh E, De Bruyne E, et al. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia. 2007;21(7):1580\u20134. https:\/\/doi.org\/10.1038\/sj.leu.2404658.","journal-title":"Leukemia."},{"issue":"10","key":"8280_CR31","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/cncr.11072","volume":"97","author":"VM Lauta","year":"2003","unstructured":"Lauta VM. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer. 2003;97(10):2440\u201352. https:\/\/doi.org\/10.1002\/cncr.11072.","journal-title":"Cancer."},{"issue":"12","key":"8280_CR32","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1210\/jcem.82.12.4450","volume":"82","author":"V Mohamed-Ali","year":"1997","unstructured":"Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82(12):4196\u2013200. https:\/\/doi.org\/10.1210\/jcem.82.12.4450.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"8280_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","volume":"20","author":"M Dalamaga","year":"2009","unstructured":"Dalamaga M, Karmaniolas K, Panagiotou A, Hsi A, Chamberland J, Dimas C, et al. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Cancer causes & control : CCC. 2009;20(2):193\u20139. https:\/\/doi.org\/10.1007\/s10552-008-9233-7.","journal-title":"Cancer causes & control : CCC"},{"issue":"2","key":"8280_CR34","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1046\/j.1365-2141.2000.02364.x","volume":"111","author":"M Ferlin","year":"2000","unstructured":"Ferlin M, Noraz N, Hertogh C, Brochier J, Taylor N, Klein B. Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway. Br J Haematol. 2000;111(2):626\u201334. https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02364.x.","journal-title":"Br J Haematol"},{"issue":"5","key":"8280_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1600-0609.2008.01127.x","volume":"81","author":"J Caers","year":"2008","unstructured":"Caers J, Vande Broek I, De Raeve H, Michaux L, Trullemans F, Schots R, et al. Multiple myeloma--an update on diagnosis and treatment. Eur J Haematol. 2008;81(5):329\u201343. https:\/\/doi.org\/10.1111\/j.1600-0609.2008.01127.x.","journal-title":"Eur J Haematol"},{"issue":"6","key":"8280_CR36","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1172\/JCI128372","volume":"129","author":"I Borrello","year":"2019","unstructured":"Borrello I, Imus PH. BCMA CAR T cells: the winding path to success. J Clin Invest. 2019;129(6):2175\u20137. https:\/\/doi.org\/10.1172\/JCI128372.","journal-title":"J Clin Invest"},{"key":"8280_CR37","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(12)61899-6","volume":"380","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet (London, England). 2012;380:2063\u20136.","journal-title":"Lancet (London, England)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08280-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08280-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08280-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T13:03:09Z","timestamp":1621947789000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08280-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8280"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08280-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data released from the Global Health Data Exchange query did not require informed patient consent. This is a public database study that reuses data from GBD study to evaluate disease burden. It is observational and does not require ethical approval and consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"606"}}